About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Cleveland | 11,559 Studies Near You

Clinical TrialsCleveland

Clinical Trials in Cleveland

Discover 11,559 clinical trials near Cleveland, Ohio. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 2221-2240 of 11,559 trials

CompletedA Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial HypertensionThis trial is a study of Remodulin in patients with pulmonary arterial hypertension who have been transitioned from Flolan therapy.NCT00058929·Los Angeles, California and 7 others RecruitingBLOCK-SAH - PPF-Block for Post-SAH HeadacheBLOCK-SAH is a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design (SPCD) of bilateral…NCT06008795·Gainesville, Florida and 12 others

Find Trials by Condition in Cleveland

Breast Cancerin Cleveland Lung Cancerin Cleveland Prostate Cancerin Cleveland Colorectal Cancerin Cleveland Melanomain Cleveland Leukemiain Cleveland Lymphomain Cleveland Pancreatic Cancerin Cleveland Ovarian Cancerin Cleveland Brain Cancerin Cleveland

Data from ClinicalTrials.govTerms

Active not recruitingTazemetostat in Treating Patients With Recurrent Ovarian or Endometrial CancerThis phase II trial studies how well tazemetostat works in treating patients with ovarian or endometrial cancer that has come back (recurrent).NCT03348631·Anchorage, Alaska and 580 others

RecruitingA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsThis phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed…NCT04293562·Birmingham, Alabama and 205 others

RecruitingA Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial ExtensionThe objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.NCT06040827·Fayetteville, Arkansas and 6 others

RecruitingSternal Plating High RiskParticipants are being invited to participate in a research study at University Hospitals because they have heart disease and are scheduled for open heart surgery.NCT06660186·Cleveland, Ohio

CompletedRandomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent RestenosisThe objective of this study is to evaluate the safety and effectiveness of the TAXUS Express2 Paclitaxel-Eluting Coronary Stent System as compared to brachytherapy in patients…NCT00287573·Birmingham, Alabama and 41 others

CompletedLong-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenThis randomized multicenter phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual…NCT03271489·Birmingham, Alabama and 156 others

TerminatedA Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaGDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (AML).NCT05886491·Birmingham, Alabama and 10 others

CompletedNivolumab in Combination With Ipilimumab (Part 1); Nivolumab Plus Ipilimumab in Combination With Chemotherapy (Part 2) as First Line Therapy in Stage IV Non-Small Cell Lung CancerThe purpose of part 1 of this study is to determine the objective response rate (ORR) in stage IV NSCLC subjects treated with nivolumab in combination with ipilimumab as first…NCT02659059·San Diego, California and 31 others

Active not recruitingProject 3: ACHIEVE- CHDThis project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the…NCT05918380·Cleveland, Ohio

CompletedStudy of Dupilumab and Immune Responses in Adults With Atopic Dermatitis (AD)This was a 32-week, randomized, double-blind, placebo-controlled, parallel-group study assessing immunization responses to vaccination in adults with moderate to severe atopic…NCT02210780·Birmingham, Alabama and 41 others

Active not recruitingA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX022 (sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsNCT06653842·Irvine, California and 9 others

CompletedA Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia RepairThis study will evaluate the safety and efficacy of two different dose regimens (12 milligrams \[mg\] and 24 mg) of IV MOA-728 versus placebo in shortening the time to return of…NCT00528970·Benton, Arkansas and 105 others

CompletedA Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy PatientsA prospective, double-blind, randomized, placebo and active controlled, multi-center, parallel group study comparing remimazolam to placebo, with an additional open-label arm for…NCT02290873·Mobile, Alabama and 12 others

CompletedStudy to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid TumorsThe purpose of this study is to evaluate the pharmacokinetics of 14C-labeled gilteritinib, in particular, the routes of excretion and extent of metabolism of gilteritinib…NCT02456883·Cleveland, Ohio

Active not recruitingA Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRASThe purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in combination with chemotherapy in…NCT06008093·Beverly Hills, California and 46 others

CompletedThe PIONEER-01 Study of the Imagio Breast Imaging SystemThis is a prospective controlled multi-center study involving gray scale (B-mode) ultrasound vs OA/US (opto-acoustic and gray scale ultrasound) for the visualization of suspicious…NCT01943916·Murrieta, California and 15 others

Active not recruitingCitadel Embolization Device StudyThe purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel…NCT04057352·Los Angeles, California and 24 others

CompletedStudy of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)The purpose of this study is to evaluate desmoteplase (which is a manufactured protein derived from the saliva of the vampire bat) in dissolving clots that are blocking the flow…NCT00111852·Birmingham, Alabama and 43 others

PreviousPage 112 of 578Next

Diabetes

in Cleveland

Heart Diseasein Cleveland